A Phase III Long-Term Study of TK-041 in Patients with Pruritus Accompanied by Skin Diseases

Trial Profile

A Phase III Long-Term Study of TK-041 in Patients with Pruritus Accompanied by Skin Diseases

Completed
Phase of Trial: Phase III

Latest Information Update: 08 Feb 2017

At a glance

  • Drugs Rupatadine (Primary)
  • Indications Dermatitis; Eczema; Pruritus; Urticaria
  • Focus Registrational; Therapeutic Use
  • Sponsors Teikoku Seiyaku
  • Most Recent Events

    • 07 Feb 2017 Status changed from active, no longer recruiting to completed.
    • 07 Jun 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top